These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Migraine, menopause and hormonal replacement therapy. Silberstein SD; de Lignières B Cephalalgia; 2000 Apr; 20(3):214-21. PubMed ID: 10997776 [No Abstract] [Full Text] [Related]
24. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition. Down RH; Whiting MJ; Watts JM; Jones W Gut; 1983 Mar; 24(3):253-9. PubMed ID: 6826111 [TBL] [Abstract][Full Text] [Related]
25. [The behavior of the gonadotropins FSH and LH during and after treatment with estrogenic and progestational drugs]. Ramadori P; Lirosi G Patol Clin Ostet Ginecol; 1973; 1(1):26-34. PubMed ID: 4143256 [No Abstract] [Full Text] [Related]
26. Inhibition of 16-androstene biosynthesis in boar testis preparations by known and new steroids. Kaufmann G; Schubert K J Steroid Biochem; 1980 Mar; 13(3):351-8. PubMed ID: 7392611 [No Abstract] [Full Text] [Related]
27. Effects of 17 beta-estradiol, synthetic estrogens, and antiestrogens on prolactin secretion, nuclear translocation of pituitary estrogen receptor and on progesterone receptor levels in rat pituitary, hypothalamus and uterus. Leibl H; Bieglmayer C; Spona J Endocrinol Exp; 1981; 15(1):35-44. PubMed ID: 6971219 [TBL] [Abstract][Full Text] [Related]
28. Prenatal exposure of human foetuses to synthetic progestin and oestrogen affects personality. Reinisch JM Nature; 1977 Apr; 266(5602):561-2. PubMed ID: 859624 [No Abstract] [Full Text] [Related]
29. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives. Bowles SM; Mills RJ Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136 [TBL] [Abstract][Full Text] [Related]
30. Prenatal exposure to synthetic progestins and estrogens: effects on human development. Reinisch JM; Karow WG Arch Sex Behav; 1977 Jul; 6(4):257-88. PubMed ID: 889431 [No Abstract] [Full Text] [Related]
31. Effect of progestins on glucose and lipid metabolism. Beck P Ann N Y Acad Sci; 1977 Mar; 286():434-45. PubMed ID: 102234 [TBL] [Abstract][Full Text] [Related]
32. Effect of estrogen/progestin potency on clinical chemistry measures. The Lipid Research Clinics Program Prevalence Study. Walden CE; Knopp RH; Johnson JL; Heiss G; Wahl PW; Hoover JJ Am J Epidemiol; 1986 Mar; 123(3):517-31. PubMed ID: 3946398 [TBL] [Abstract][Full Text] [Related]
33. The physiological action of progesterone and the pharmacological effects of progestogens--a short review. Neumann F Postgrad Med J; 1978; 54 Suppl 2():11-24. PubMed ID: 368741 [TBL] [Abstract][Full Text] [Related]
34. Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium. Lüdicke F; Johannisson E; Helmerhorst FM; Campana A; Foidart J; Heithecker R Fertil Steril; 2001 Jul; 76(1):102-7. PubMed ID: 11438327 [TBL] [Abstract][Full Text] [Related]
35. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria. King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244 [TBL] [Abstract][Full Text] [Related]
36. [Gonadotropic function during its use and after its cessation of a triphasic combination of gestodene]. Levaillant JM; Levaillant C; Colin MC; Rotten D Rev Fr Gynecol Obstet; 1988 Oct; 83(10):655-61. PubMed ID: 3144031 [TBL] [Abstract][Full Text] [Related]
37. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake. Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649 [TBL] [Abstract][Full Text] [Related]
38. Lysozyme (muramidase) and hemolytic complement (CH50U) in sera of beagle dogs and minipigs after longterm application of different preparations of estrogens and gestagens. Stelzner A; Klinger G; Oettel M; Hoffmann H; Hillesheim HG; Chemnitius KH; Schimke E; Zieger M Arch Toxicol Suppl; 1980; 4():159-62. PubMed ID: 6933895 [TBL] [Abstract][Full Text] [Related]
39. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel. Sabra A; Bonnar J J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350 [TBL] [Abstract][Full Text] [Related]